Quadrant Private Wealth Management
AZN icon

Quadrant Private Wealth Management’s AstraZeneca AZN Stock Holding History

Quadrant Private Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,224
Closed -$232K – 328
2026
Q2 		$232K Buy
1,224
+4
+0.3% +$752 0.05% 152
2026
Q1 		$241K Buy
+1,220
New +$235K 0.04% 254

Other funds holding AZN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Quadrant Private Wealth Management's AZN Position: Q3 2026 in Review

Quadrant Private Wealth Management sold out of AstraZeneca (AZN) in Q3 2026, closing a stake of 1,224 shares — an estimated $232K sold.

Quadrant Private Wealth Management first reported a position in AZN in Q1 2026 and held it in 2 quarters. The position peaked at $241K in Q1 2026. 918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Quadrant Private Wealth Management reported no remaining AstraZeneca position as of Q3 2026 after selling out during the quarter.
  • Quadrant Private Wealth Management sold 1,224 AstraZeneca shares in Q3 2026, an estimated $232K.
  • Quadrant Private Wealth Management first reported a position in AstraZeneca in Q1 2026 and held it in 2 quarters.
  • Quadrant Private Wealth Management's AstraZeneca position peaked at $241K in Q1 2026.
  • 918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Quadrant Private Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.